Watchdog clears Omar of misconduct after probe into financial filings
The Office of Congressional Conduct has dismissed allegations that Rep. Ilhan Omar engaged in misconduct over inflated financial disclosures, her office said. An Omar spokesperson announced Wednesday that the watchdog delivered an "overwhelming vote to dismiss any allegations against the Congresswoman."

Why It Matters
A formal dismissal by Congress’s official ethics watchdog removes an institutional allegation of financial-reporting misconduct against a sitting member, resolving a scrutiny that was directed at Rep. Omar. The outcome affects both her official record and public account of the accusations, as presented by her office.
Key Facts
- Subject: Rep. Ilhan Omar (D-Minn.)
- Allegation: Misconduct related to inflated financial filings
- Decision-maker: Office of Congressional Conduct (OCC)
- Outcome: OCC delivered an overwhelming vote to dismiss the allegations
- Source of announcement: Statement from an Omar spokesperson, issued Wednesday
Rep. Ilhan Omar’s office said the Office of Congressional Conduct (OCC) has dismissed allegations that she committed misconduct by inflating financial filings. The statement, released Wednesday by an Omar spokesperson, said the OCC "delivered an overwhelming vote to dismiss any allegations against the Congresswoman."
The spokesperson’s release included the opening words "From day one, we have..." but the full quotation was not provided in the item summarizing the announcement. The office framed the OCC vote as a clear resolution in Omar’s favor.
The OCC is the official ethics body for Congress, and its vote to dismiss the claims was presented by Omar’s team as the decisive outcome of the matter. The office’s statement served as the primary public account of the watchdog’s action in this instance.
Keep Reading

Live updates: Trump, Republicans converge on Dallas as GOP midterm convention opens

Watch live: Trump to headline first GOP midterm convention

Lindsay Clancy attorney will ask for jury to be sequestered in new trial
